https://www.thepharmaletter.com/pharma-news/bioalliance-pharma-s-sitavig-oked-by-us-fda-for-herpes-labialis
BioAlliance Pharma's Sitavig OKed by US FDA for Herpes labialis | Pharmaceutical | The Pharmaletter
French drugmaker BioAlliance Pharma (Euronext Paris - BIO) has received marketing authorization from the US Food and Drug Administration for Sitavig (acyclovir
us fdaherpes labialispharmasitavigoked